Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8237553 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 11 Pages |
Abstract
Patients with IBC who are able to complete treatment with chemotherapy, mastectomy, and postmastectomy radiation have a high probability of locoregional control. Escalation of postmastectomy radiation dose to 66 Gy appears to benefit patients with disease that responds poorly to chemotherapy, those with positive, close, or unknown margin status, and those <45 years of age.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ian J. M.D., Wendy A. M.D., Ph.D., Eric A. M.D., Massimo M.D., Delora B.S., S. Eva M.D., George H. M.D., Julia L. M.D., Tse-Kuan M.D., Ph.D., Welela M.D., Aysegul A. M.D., Kelly K. M.D., Gabriel N. M.D., Thomas A. M.D.,